• 2Q24 revenues of $681.5 million

• 2Q24 net income of $73.0 million, adjusted EBITDA⁽¹⁾ of $126.2 million

• 2Q24 diluted GAAP EPS of $0.79, non-GAAP⁽¹⁾ EPS of $0.82

• BWXT-led JV awarded management and operations contract for the NNSA’s Pantex Plant

• 2024 non-GAAP EPS⁽¹⁾ guidance revised to $3.10-$3.20

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2024 results. A reconciliation of non-GAAP results are detailed in Exhibit 1.

“In recent months there have been multiple important developments supporting our nuclear markets, including passage of the ADVANCE Act, federal and state legislation supporting small modular reactor development and the Army and Defense Innovation Unit’s acquisition plans for microreactors at remote military bases, all of which have been complemented by broad-based support from private industry,” continued Geveden. “These developments demonstrate the increasing appetite for nuclear solutions across the global security, clean energy, and medical markets, ultimately driving new and exciting opportunities for BWXT.”

“Overall, we had a solid first half both financially and strategically and we continue to see favorable demand momentum in our end-markets,” continued Geveden. “Based on our year-to-date performance and anticipated progress on key contracts during the second half of the year, we are narrowing our 2024 non-GAAP EPS guidance to $3.10- $3.20.”